图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
环境病理学,毒理学和肿瘤学期刊
影响因子: 1.241 5年影响因子: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN 打印: 0731-8898
ISSN 在线: 2162-6537

环境病理学,毒理学和肿瘤学期刊

DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i4.70
pages 303-305

The Food and Drug Administration Agrees to Classify Mercury Fillings

Richard Edlich
Legacy Verified Level I Shock Trauma Center Pediatrics and Adults, Legacy Emanual Hospital; and Plastic Surgery, Biomedical Engineering and Emergency Medicine, University of Virginia Health System, USA
Catherine L. Cross
Legacy Emanuel Hospital, Portland, OR, USA
Courtney A. Wack
Legacy Emanuel Hospital, Portland, OR, USA
William B. Long III
Trauma Specialists LLP, Legacy Verified Level I Shock Trauma Center for Pediatrics and Adults, Legacy Emmanuel Hospital Portland, OR, USA
Anthony T. Newkirk
Synergy Dental, Portland, OR, USA

ABSTRACT

In the United States Court of Appeals of the District of Columbia Circuit, the Appellants Mom's Against Mercury, Connecticut Coalition for Environmental Justice, Oregonians for Life, California Citizens for Health Freedom, Kevin J. Biggers, Karen Johnson, Linda Brocato, R. Andrew Landerman, and Antia Vazquez Tibaul filed a petition for review of Regulatory Inaction by the Food and Drug Administration (FDA). On Monday June 2, 2008, the lawsuit was settled with the FDA after it agreed to classify mercury fillings. During its negotiation session with the Appellants, the FDA indicated that it would change its website on mercury fillings. The FDA no longer claims that no science exists about the safety of mercury amalgam or that other countries have acted for environmental reasons only. On its website, the FDA now states the following: "Dental amalgams contain mercury, which may have neurotoxic effects on the nervous systems of developing children and fetus." The FDA also states that "Pregnant women and persons who may have a health condition that makes them more sensitive to mercury exposure, including individuals with existing high levels of mercury bioburden, should not avoid seeking dental care, but should discuss options with their health practitioner." The FDA decision to classify mercury fillings is a reflection of the legislations enacted in Europe and Canada that highlight the neurotoxic effects of mercury fillings.


Articles with similar content:

Implementation of Revolutionary Legislation for Informed Consent for Dental Patients Receiving Amalgam Restorations
Journal of Environmental Pathology, Toxicology and Oncology, Vol.27, 2008, issue 1
Jill J. Dahlstrom, William B. Long III, Richard Edlich, Anthony T. Newkirk, Catherine L. Cross
Government and Private Insurance Medical Programs as well as MDVIP, an Update
Journal of Long-Term Effects of Medical Implants, Vol.14, 2004, issue 3
Gloria Anima, William B. Long III, Richard Edlich, Kathryne L. Winters, L. D. Britt
Treated Wood Preservatives Linked to Aquatic Damage, Human Illness, and Death—A Societal Problem
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 2
William B. Long III, Richard Edlich, Kathryne L. Winters
Abstract of "Seeing the Power Struggle Between Doctors, Lawyers, and Patients Through a Foucauldian Point of View−a Need for Medical Liability Reform"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Karren M. Takamura
Abstract of "U.S. Health Care in Crisis: A Case for Treating the "Perfect Storm" with the VHA Model"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Jeffrey P. Weiss